1.
Smita Tukaram Kumbhar, Manish Sudesh Bhatia, Shitalkumar Shivgonda Patil. Engineered atenolol-glycoconjugates to target H9c2 cardiomyocyte cell lines. ACTA INNOVATIONS [Internet]. 2022 Jun. 30 [cited 2025 May 3];43:36-43. Available from: https://www.actainnovations.com/index.php/pub/article/view/43_3